Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Iron Dextran for Anemia in Pregnancy
NCT02038023Phase 2Completed
- Sponsor
- Auerbach Hematology Oncology Associates
- Start
- Jul 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of iron dextran in iron deficiency anemia (IDA), sponsored by Auerbach Hematology Oncology Associates. Primary endpoint: Percentage of Women Who Achieve Anemia Correction at 4 weeks. Started Jul 2013; status: completed.
02
Drugs
iron dextran
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT02038023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02038023.